METHOD OF TREATING AGE-RELATED MACULAR RETINAL DEGENERATION Russian patent published in 2011 - IPC A61F9/00 A61N5/67 A61K35/44 A61P27/02 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly - to ophthalmology. The method involves laser exposure and retinalamine administration For this purpose, retinalamine 5 mg is dissolved in 2% lidocaine 1.5 ml. Parabulbarly, the prepared solution is introduced by 75 ml into each eye. 5-10 minutes later, retina focused continuous noncontact exposure to helium-neon laser follows. The light guide diametre is 3 mm, the distance of a distal end of the light guide to a front surface of cornea is 2-4 cm. The power is 2.2 - 2.6 Wt. Said combined exposure is daily for ten days. The duration of first three sessions of laser exposure is 3 minutes, and the following seven sessions of laser exposure last for 5 minutes.

EFFECT: method improves visual functions due to enhancing visual acuity and extending fields of vision, provides continuous stable maintenance of the effect; it is atraumatic.

3 ex